Trials / Completed
CompletedNCT01655290
Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI
Single Dose Gadobutrol in Comparison to Single Dose Gadobenate Dimeglumine for Magnetic Resonance Imaging of Chronic Myocardial Infarction at 3 Tesla
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at evaluating the diagnostic efficacy of Gadobutrol versus Gadobenate dimeglumine at similar dose of 0.1mmol/kg for assessment of myocardial infarction by delayed enhancement cardiac Magnetic Resonance Imaging
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Gadovist® (Gadobutrol), Multihance® (Gadobenate dimeglumin) | Other (Diagnostic) |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-05-01
- Completion
- 2014-06-01
- First posted
- 2012-08-01
- Last updated
- 2020-10-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01655290. Inclusion in this directory is not an endorsement.